APA (7th ed.) Citation

Helmschrott, M., Rivinius, R., Bruckner, T., Katus, H., & Dösch, A. (2017). Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy. Drug design, development and therapy, 11, . https://doi.org/10.2147/DDDT.S135503

Chicago Style (17th ed.) Citation

Helmschrott, Matthias, Rasmus Rivinius, Thomas Bruckner, Hugo Katus, and Andreas Dösch. "Renal Function in Heart Transplant Patients After Switch to Combined Mammalian Target of Rapamycin Inhibitor and Calcineurin Inhibitor Therapy." Drug Design, Development and Therapy 11 (2017). https://doi.org/10.2147/DDDT.S135503.

MLA (9th ed.) Citation

Helmschrott, Matthias, et al. "Renal Function in Heart Transplant Patients After Switch to Combined Mammalian Target of Rapamycin Inhibitor and Calcineurin Inhibitor Therapy." Drug Design, Development and Therapy, vol. 11, 2017, https://doi.org/10.2147/DDDT.S135503.